Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 20.

Curioni-Fontecedro, A; Pitocco, R; Schoenewolf, N L; Holzmann, D; Soldini, D; Dummer, R; Calvieri, S; Moch, H; Mihic-Probst, D; Fitsche, A (2015). Intratumoral heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 expression in mucosal melanoma. BioMed Research International, 2015:432479.

Mihic-Probst, D; Beer, M (2013). Lichtblicke beim schwarzen Hautkrebs aus der Sicht von Pathologen. Praxis, 102(4):219-224.

von Moos, R; Seifert, B; Simcock, M; Goldinger, S M; Gillessen, S; Ochsenbein, A; Michielin, O; Cathomas, R; Schläppi, M; Moch, H; Schraml, P H; Mihic-Probst, D; Mamot, C; Schönewolf, N; Dummer, R (2012). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Annals of Oncology, 23(2):531-536.

Schraml, P; von Teichmann, A; Mihic-Probst, D; Simcock, M; Ochsenbein, A; Dummer, R; Michieilin, O; Seifert, B; Schläppi, M; Moch, H; von Moos, R (2012). Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07. Oncology Reports, 28(2):654-658.

Schoenewolf, N L; Bull, C; Belloni, B; Holzmann, D; Tonolla, S; Lang, R; Mihic-Probst, D; Andres, C; Dummer, R (2012). Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations. European Journal of Cancer, 48(12):1842-1852.

Mihic-Probst, D. Molecular biomarkers for malignant melanoma: Implications for diagnosis, tumor-progression and prognosis. 2011, University of Zurich, Faculty of Medicine.

Lee, S B; Doberstein, K; Baumgarten, P; Wieland, A; Ungerer, C; Bürger, C; Hardt, K; Boehncke, W H; Pfeilschifter, J; Mihic-Probst, D; Mittelbronn, M; Gutwein, P (2011). PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells. PLoS ONE, 6(8):e22312.

Navarini, A A; Bauer, J; Barysch, M J; Kempf, W; Mihic-Probst, D; Kerl, K; Kamarashev, J; Giovanoli, P; Kolios, A G A; Bergstraesser, E; Dummer, R (2011). Spitzoid melanoma and micrometastases in two lymph node regions: a critical situation. European Journal of Dermatology, 21(2):229-233.

Goesseringer, N; Lindenblatt, N; Mihic-Probst, D; Grimm, F; Giovanoli, P (2011). Taenia crassiceps upper limb fasciitis in a patient with untreated acquired immunodeficiency syndrome and chronic hepatitis C infection--the role of surgical debridement. Journal of Plastic, Reconstructive & Aesthetic Surgery, 64(7):e174-e176.

Lee, S B; Schramme, A; Doberstein, K; Dummer, R; Abdel-Bakky, M S; Keller, S; Altevogt, P; Oh, S T; Reichrath, J; Oxmann, D; Pfeilschifter, J; Mihic-Probst, D; Gutwein, P (2010). ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. Journal of Investigative Dermatology, 130(3):763-773.

Ungerer, C; Doberstein, K; Bürger, C; Hardt, K; Boehncke, W H; Böhm, B; Pfeilschifter, J; Dummer, R; Mihic-Probst, D; Gutwein, P (2010). ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma. Biochemical and Biophysical Research Communications (BBRC), 401(3):363-369.

Labler, L; Rancan, M; Härter, L; Mihic-Probst, D; Keel, M; Mica, L (2009). Vacuum-assisted closure therapy increases local interleukin-8 and vascular endothelial growth factor levels in traumatic wounds. Journal of Trauma, 66(3):749-757.

Beer, G M; Schuster, A; Seifert, Burkhardt; Manestar, M; Mihic-Probst, D; Weber, S A (2009). The normal width of the linea alba in nulliparous women. Clinical Anatomy, 22(6):706-711.

Reschke, M; Mihic-Probst, D; van der Horst, E H; Knyazev, P; Wild, P J; Hutterer, M; Meyer, S; Dummer, R; Moch, H; Ullrich, A (2008). HER3 is a determinant for poor prognosis in melanoma. Clinical Cancer Research, 14(16):5188-5197.

Guggenheim, M; Dummer, R; Jung, F J; Mihic-Probst, D; Steinert, H; Rousson, V; French, L E; Giovanoli, P (2008). The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma - a retrospective analysis of 392 cases. British Journal of Cancer, 98(12):1922-1928.

Meyer, E P; Beer, G M; Lang, A; Manestar, M; Krucker, T; Meier, S; Mihic-Probst, D; Groscurth, P (2007). Polyurethane elastomer: a new material for the visualization of cadaveric blood vessels. Clinical Anatomy, 20(4):448-454.

Mihic-Probst, D; Kuster, A; Kilgus, S; Bode-Lesniewska, B; Ingold-Heppner, B; Leung, C; Storz, M; Seifert, Burkhardt; Marino, S; Schraml, P; Dummer, R; Moch, H (2007). Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. International Journal of Cancer, 121(8):1764-1770.

Beer, G M; Baumüller, S; Zech, N; Wyss, P; Strasser, D; Varga, Z; Seifert, Burkhardt; Hafner, J; Mihic-Probst, D (2006). Immunohistochemical differentiation and localization analysis of sweat glands in the adult human axilla. Plastic and Reconstructive Surgery, 117(6):2043-2049.

Mihic-Probst, D; Mnich, C D; Oberholzer, P A; Seifert, Burkhardt; Sasse, B; Moch, H; Dummer, R (2006). p16 expression in primary malignant melanoma is associated with prognosis and lymph node status. International Journal of Cancer, 118(9):2262-2268.

Mihic-Probst, D; Zhao, J; Saremaslani, P; Baer, A; Komminoth, P; Heitz, P U (2001). Spitzoid malignant melanoma with lymph-node metastasis. Is a copy-number loss on chromosome 6q a marker of malignancy? Virchows Archiv, 439(6):823-826.

This list was generated on Wed Sep 20 15:23:08 2017 CEST.